Related Experiment Video
Updated: Jul 28, 2026
The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
Published on: May 16, 2012
A simple saliva-based test for detecting antibodies to human immunodeficiency virus
W Schramm1, G B Angulo, P C Torres
1Saliva Diagnostic Systems, Inc., Vancouver, Washington 98682, USA.
Insights
A new saliva test kit (ST) offers a feasible method for detecting human immunodeficiency virus (HIV) antibodies outside of labs. This non-invasive approach shows high accuracy, making it suitable for field use in resource-limited settings.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- Traditional HIV testing relies on laboratory-based serum analysis.
- Non-laboratory diagnostic methods are needed for widespread, accessible screening.
- Saliva offers a non-invasive alternative for antibody detection.
Purpose of the Study:
- To assess the feasibility of using saliva for human immunodeficiency virus type 1 (HIV-1) and HIV-2 antibody detection.
- To evaluate the performance characteristics of a novel self-contained saliva test kit (ST) under non-laboratory conditions.
- To determine the suitability of the saliva test for field applications with limited laboratory support.
Main Methods:
- Development of a self-contained kit (Saliva. Strip [ST]) for saliva collection, processing, and analysis.
- Evaluation of the ST kit in a blinded study involving 1,336 matched serum and saliva specimens.
- Comparison of ST kit performance against enzyme immunoassay (EIA) and serum strip tests, with Western blotting for confirmation.
Main Results:
- The ST saliva test demonstrated high sensitivity (99.4%) and specificity (99.4%).
- Performance was comparable to laboratory-based EIA (100% sensitivity, 99.1% specificity) and serum strip tests (99.7% sensitivity, 100% specificity).
- The saliva test performed well even with diluted HIV-2 positive sera and low-titer HIV-1 specimens.
Conclusions:
- The Saliva. Strip (ST) kit is a feasible and accurate tool for detecting HIV antibodies in saliva.
- The non-invasive nature and high performance make it ideal for field use in diverse settings.
- This methodology can enhance HIV surveillance and accessibility in resource-limited environments.
Abstract:
This study was performed to determine the feasibility of using saliva as a diagnostic medium for the detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 under nonlaboratory conditions and to evaluate the performance characteristics of such a test. We developed for this purpose a self-contained kit (Saliva. Strip [ST]), which combines the collection and processing, as well as the analysis, of the specimen. The kit's performance was evaluated in a blinded study. Saliva collection was facilitated with a specially designed device that contains a sample adequacy indicator, and immunochromatography test strips were used for the analysis. A total of 1,336 matched serum and saliva specimens (684 reactive and 652 nonreactive specimens) were tested. We tested sera using an enzyme immunoassay (EIA) and a rapid strip test. Sera reactive in one of the assays were also analyzed by Western blotting. Sensitivity and specificity were 99.4 and 99.4%, respectively, for ST, 100 and 99.1%, respectively, for EIA, and 99.7 and 100%, respectively, for the serum strip test. The saliva test performed well when HIV-2-positive sera or a low-titer performance panel (HIV-1) of serum or plasma specimens were diluted (1:2,000) in nonreactive saliva. Because the methodology we present here uses a noninvasively obtained medium, the methodology may be suitable for use in the field where laboratory support and personnel are limited, such as community outreach programs, doctors' offices, surveillance studies, and community hospitals.
